Clinical Trial Update: A Study to Assess Efficacy and Safety of HL036 in Subjects With Dry Eyes [Phase 3]

View source ↗

Summary

Phase 3 trial assessing HL036 for dry eye completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye

Drugs mentioned

• HL036 (HL036)

Snippet

Sponsor: HanAll BioPharma Co., Ltd. | Conditions: Dry Eye | Phase 3 | Status: COMPLETED | Results posted: 2022-04-14